• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RNF208,一种雌激素诱导的 E3 连接酶,靶向可溶性波形蛋白以抑制三阴性乳腺癌的转移。

RNF208, an estrogen-inducible E3 ligase, targets soluble Vimentin to suppress metastasis in triple-negative breast cancers.

机构信息

Precision Medicine Research Center, Advanced Institute of Convergence Technology, Seoul National University, Suwon, Gyeonggi-do, 16229, Republic of Korea.

Department of Biomedical Science, College of Life Science, CHA University, Seongnam City, Gyeonggi-do, 463-400, Republic of Korea.

出版信息

Nat Commun. 2019 Dec 20;10(1):5805. doi: 10.1038/s41467-019-13852-5.

DOI:10.1038/s41467-019-13852-5
PMID:31862882
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6925134/
Abstract

The development of triple-negative breast cancer (TNBC) negatively impacts both quality of life and survival in a high percentage of patients. Here, we show that RING finger protein 208 (RNF208) decreases the stability of soluble Vimentin protein through a polyubiquitin-mediated proteasomal degradation pathway, thereby suppressing metastasis of TNBC cells. RNF208 was significantly lower in TNBC than the luminal type, and low expression of RNF208 was strongly associated with poor clinical outcomes. Furthermore, RNF208 was induced by 17β-estradiol (E2) treatment in an estrogen receptor alpha (ΕRα)-dependent manner. Overexpression of RNF208 suppresses tumor formation and lung metastasis of TNBC cells. Mechanistically, RNF208 specifically polyubiquitinated the Lys97 residue within the head domain of Vimentin through interaction with the Ser39 residue of phosphorylated Vimentin, which exists as a soluble form, eventually facilitating proteasomal degradation of Vimentin. Collectively, our findings define RNF208 as a negative regulator of soluble Vimentin and a prognostic biomarker for TNBC cells.

摘要

三阴性乳腺癌(TNBC)的发展对大多数患者的生活质量和生存产生负面影响。在这里,我们表明 RING 指蛋白 208(RNF208)通过多泛素化介导的蛋白酶体降解途径降低可溶性波形蛋白的稳定性,从而抑制 TNBC 细胞的转移。RNF208 在 TNBC 中的表达明显低于腔型,RNF208 的低表达与不良临床结局密切相关。此外,RNF208 被 17β-雌二醇(E2)以雌激素受体α(ΕRα)依赖性方式诱导。RNF208 的过表达抑制 TNBC 细胞的肿瘤形成和肺转移。在机制上,RNF208 通过与磷酸化波形蛋白的 Ser39 残基相互作用,特异性地多泛素化波形蛋白头部结构域中的 Lys97 残基,从而促进波形蛋白的蛋白酶体降解。总之,我们的研究结果将 RNF208 定义为可溶性波形蛋白的负调节剂和 TNBC 细胞的预后生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e23/6925134/f41a95a8875a/41467_2019_13852_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e23/6925134/eb29460ae1cc/41467_2019_13852_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e23/6925134/98c327883ee4/41467_2019_13852_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e23/6925134/448d031fb441/41467_2019_13852_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e23/6925134/1991fb8844d6/41467_2019_13852_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e23/6925134/a36ca7aa96c0/41467_2019_13852_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e23/6925134/78623c293335/41467_2019_13852_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e23/6925134/f41a95a8875a/41467_2019_13852_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e23/6925134/eb29460ae1cc/41467_2019_13852_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e23/6925134/98c327883ee4/41467_2019_13852_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e23/6925134/448d031fb441/41467_2019_13852_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e23/6925134/1991fb8844d6/41467_2019_13852_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e23/6925134/a36ca7aa96c0/41467_2019_13852_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e23/6925134/78623c293335/41467_2019_13852_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e23/6925134/f41a95a8875a/41467_2019_13852_Fig7_HTML.jpg

相似文献

1
RNF208, an estrogen-inducible E3 ligase, targets soluble Vimentin to suppress metastasis in triple-negative breast cancers.RNF208,一种雌激素诱导的 E3 连接酶,靶向可溶性波形蛋白以抑制三阴性乳腺癌的转移。
Nat Commun. 2019 Dec 20;10(1):5805. doi: 10.1038/s41467-019-13852-5.
2
RNF144A functions as a tumor suppressor in breast cancer through ubiquitin ligase activity-dependent regulation of stability and oncogenic functions of HSPA2.RNF144A 通过依赖于泛素连接酶活性的 HSPA2 稳定性和致癌功能的调节,在乳腺癌中作为肿瘤抑制因子发挥作用。
Cell Death Differ. 2020 Mar;27(3):1105-1118. doi: 10.1038/s41418-019-0400-z. Epub 2019 Aug 13.
3
E3 Ubiquitin Ligase UBR5 Drives the Growth and Metastasis of Triple-Negative Breast Cancer.UBR5 E3 泛素连接酶驱动三阴性乳腺癌的生长和转移。
Cancer Res. 2017 Apr 15;77(8):2090-2101. doi: 10.1158/0008-5472.CAN-16-2409. Epub 2017 Mar 22.
4
Cancer Testis Antigen Promotes Triple Negative Breast Cancer Metastasis and is Traceable in the Circulating Extracellular Vesicles.癌症睾丸抗原促进三阴性乳腺癌转移,并可在外泌体中追踪。
Sci Rep. 2019 Aug 12;9(1):11632. doi: 10.1038/s41598-019-48064-w.
5
Disulfiram induces anoikis and suppresses lung colonization in triple-negative breast cancer via calpain activation.双硫仑通过激活钙蛋白酶诱导三阴性乳腺癌细胞失巢凋亡并抑制肺转移。
Cancer Lett. 2017 Feb 1;386:151-160. doi: 10.1016/j.canlet.2016.11.022. Epub 2016 Nov 25.
6
E1A-mediated inhibition of HSPA5 suppresses cell migration and invasion in triple-negative breast cancer.E1A介导的HSPA5抑制作用可抑制三阴性乳腺癌细胞的迁移和侵袭。
Ann Surg Oncol. 2015 Mar;22(3):889-98. doi: 10.1245/s10434-014-4061-3. Epub 2014 Sep 12.
7
The Gαh-PLCδ1 signaling axis drives metastatic progression in triple-negative breast cancer.Gαh-PLCδ1 信号轴驱动三阴性乳腺癌的转移进展。
J Hematol Oncol. 2017 Jun 2;10(1):114. doi: 10.1186/s13045-017-0481-4.
8
Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.RAB1B缺失通过激活TGF-β/SMAD信号通路促进三阴性乳腺癌转移。
Oncotarget. 2015 Jun 30;6(18):16352-65. doi: 10.18632/oncotarget.3877.
9
FBXL14 abolishes breast cancer progression by targeting CDCP1 for proteasomal degradation.FBXL14 通过靶向 CDCP1 进行蛋白酶体降解来抑制乳腺癌的进展。
Oncogene. 2018 Oct;37(43):5794-5809. doi: 10.1038/s41388-018-0372-3. Epub 2018 Jul 4.
10
Loss of the Nuclear Pool of Ubiquitin Ligase CHIP/STUB1 in Breast Cancer Unleashes the MZF1-Cathepsin Pro-oncogenic Program.乳腺癌中泛素连接酶 CHIP/STUB1 的核池缺失会释放 MZF1-组织蛋白酶的致癌程序。
Cancer Res. 2018 May 15;78(10):2524-2535. doi: 10.1158/0008-5472.CAN-16-2140. Epub 2018 Mar 6.

引用本文的文献

1
Fumiquinazolines F and G from the Fungus Demonstrates Anticancer Efficacy Against Triple-Negative Breast Cancer MDA-MB-231 Cells by Inhibiting Epithelial-Mesenchymal Transition.来自真菌的烟曲喹唑啉F和G通过抑制上皮-间质转化对三阴性乳腺癌MDA-MB-231细胞显示出抗癌功效。
Int J Mol Sci. 2025 Aug 5;26(15):7582. doi: 10.3390/ijms26157582.
2
Eomesodermin in conjunction with the BAF complex promotes expansion and invasion of the trophectoderm lineage.胚外中胚层决定因子与BAF复合体共同促进滋养外胚层谱系的扩增和侵袭。
Nat Commun. 2025 May 31;16(1):5079. doi: 10.1038/s41467-025-60417-w.
3
Loosening the Lid on Shoulder Osteoarthritis: How the Transcriptome and Metabolic Syndrome Correlate with End-Stage Disease.

本文引用的文献

1
ERβ-mediated induction of cystatins results in suppression of TGFβ signaling and inhibition of triple-negative breast cancer metastasis.雌激素受体β(ERβ)介导的胱抑素诱导导致转化生长因子β(TGFβ)信号抑制和三阴性乳腺癌转移抑制。
Proc Natl Acad Sci U S A. 2018 Oct 9;115(41):E9580-E9589. doi: 10.1073/pnas.1807751115. Epub 2018 Sep 26.
2
Estrogen receptor-α promoter methylation is a biomarker for outcome prediction of cisplatin resistance in triple-negative breast cancer.雌激素受体-α启动子甲基化是三阴性乳腺癌顺铂耐药预后预测的生物标志物。
Oncol Lett. 2018 Mar;15(3):2855-2862. doi: 10.3892/ol.2017.7637. Epub 2017 Dec 19.
3
揭开肩部骨关节炎的盖子:转录组和代谢综合征与终末期疾病的关联
Int J Mol Sci. 2025 Mar 28;26(7):3145. doi: 10.3390/ijms26073145.
4
TRIM47 promotes hypopharyngeal and laryngeal cancers progression through promoting K63-linked ubiquitination of vimentin.TRIM47通过促进波形蛋白的K63连接泛素化来促进下咽癌和喉癌的进展。
Cancer Sci. 2025 Feb;116(2):367-380. doi: 10.1111/cas.16397. Epub 2024 Nov 25.
5
Liver X Receptors Enhance Epithelial to Mesenchymal Transition in Metastatic Prostate Cancer Cells.肝脏X受体增强转移性前列腺癌细胞的上皮-间质转化
Cancers (Basel). 2024 Aug 6;16(16):2776. doi: 10.3390/cancers16162776.
6
Endothelial deubiquinatase YOD1 mediates Ang II-induced vascular endothelial-mesenchymal transition and remodeling by regulating β-catenin.内皮去泛素化酶 YOD1 通过调节β-连环蛋白介导血管内皮-间充质转化和重构。
Acta Pharmacol Sin. 2024 Aug;45(8):1618-1631. doi: 10.1038/s41401-024-01278-9. Epub 2024 Apr 19.
7
Molecular subtyping and the construction of a predictive model of colorectal cancer based on ion channel genes.基于离子通道基因的结直肠癌分子亚型分类和预测模型的构建。
Eur J Med Res. 2024 Apr 4;29(1):219. doi: 10.1186/s40001-024-01819-2.
8
The E3 ligase NEURL3 suppresses epithelial-mesenchymal transition and metastasis in nasopharyngeal carcinoma by promoting vimentin degradation.E3 连接酶 NEURL3 通过促进波形蛋白降解来抑制鼻咽癌中的上皮-间充质转化和转移。
J Exp Clin Cancer Res. 2024 Jan 9;43(1):14. doi: 10.1186/s13046-024-02945-9.
9
Vimentin takes a hike - Emerging roles of extracellular vimentin in cancer and wound healing.波形蛋白出走——细胞外波形蛋白在癌症和创伤愈合中的新作用。
Curr Opin Cell Biol. 2023 Dec;85:102246. doi: 10.1016/j.ceb.2023.102246. Epub 2023 Sep 30.
10
LAD1 promotes malignant progression by diminishing ubiquitin-dependent degradation of vimentin in gastric cancer.LAD1 通过减少胃癌中波形蛋白的泛素依赖性降解来促进恶性进展。
J Transl Med. 2023 Sep 17;21(1):632. doi: 10.1186/s12967-023-04401-2.
The ubiquitin ligase TRIM56 inhibits ovarian cancer progression by targeting vimentin.
泛素连接酶TRIM56通过靶向波形蛋白抑制卵巢癌进展。
J Cell Physiol. 2018 Mar;233(3):2420-2425. doi: 10.1002/jcp.26114. Epub 2017 Sep 12.
4
A Landscape of Pharmacogenomic Interactions in Cancer.癌症中的药物基因组学相互作用全景
Cell. 2016 Jul 28;166(3):740-754. doi: 10.1016/j.cell.2016.06.017. Epub 2016 Jul 7.
5
Assays for Posttranslational Modifications of Intermediate Filament Proteins.中间丝蛋白翻译后修饰的检测方法。
Methods Enzymol. 2016;568:113-38. doi: 10.1016/bs.mie.2015.09.005. Epub 2015 Nov 6.
6
ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer.雌激素受体β1:雌激素受体α阳性和阴性乳腺癌的特征、预后及治疗策略评估
BMC Cancer. 2014 Oct 7;14:749. doi: 10.1186/1471-2407-14-749.
7
Post-translational modifications of intermediate filament proteins: mechanisms and functions.中间丝蛋白的翻译后修饰:机制与功能。
Nat Rev Mol Cell Biol. 2014 Mar;15(3):163-77. doi: 10.1038/nrm3753.
8
TP53 mutation-correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53-mutated breast cancers.TP53突变相关基因可预测肿瘤复发风险,并确定MPS1是TP53突变型乳腺癌中一种潜在的治疗性激酶。
Mol Oncol. 2014 May;8(3):508-19. doi: 10.1016/j.molonc.2013.12.018. Epub 2014 Jan 5.
9
Genome engineering using the CRISPR-Cas9 system.使用 CRISPR-Cas9 系统进行基因组工程。
Nat Protoc. 2013 Nov;8(11):2281-2308. doi: 10.1038/nprot.2013.143. Epub 2013 Oct 24.
10
Breast cancer statistics, 2013.乳腺癌统计数据,2013 年。
CA Cancer J Clin. 2014 Jan-Feb;64(1):52-62. doi: 10.3322/caac.21203. Epub 2013 Oct 1.